» Articles » PMID: 15562254

USP19 is a Ubiquitin-specific Protease Regulated in Rat Skeletal Muscle During Catabolic States

Overview
Date 2004 Nov 25
PMID 15562254
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Ubiquitin-dependent proteolysis is activated in skeletal muscle atrophying in response to various catabolic stimuli. Previous studies have demonstrated activation of ubiquitin conjugation. Because ubiquitination can also be regulated by deubiquitinating enzymes, we used degenerate oligonucleotides derived from conserved sequences in the ubiquitin-specific protease (UBP) family of deubiquitinating enzymes in RT-PCR with skeletal muscle RNA to amplify putative deubiquitinating enzymes. We identified USP19, a 150-kDa deubiquitinating enzyme that is widely expressed in various tissues including skeletal muscle. Expression of USP19 mRNA increased by approximately 30-200% in rat skeletal muscle atrophying in response to fasting, streptozotocin-induced diabetes, dexamethasone treatment, and cancer. Increased mRNA levels during fasting returned to normal with refeeding, but 1 day later than the normalization of rates of proteolysis and coincided instead with recovery of muscle mass. Indeed, in all catabolic treatments, USP19 mRNA was inversely correlated with muscle mass and provided an index of muscle mass that may be useful in many pathological conditions, using small human muscle biopsies. The increased expression of this deubiquitinating enzyme under conditions of increased proteolysis suggests that it may play a role in regeneration of free ubiquitin either coincident with or after proteasome-mediated degradation of substrates. USP19 may also be involved in posttranslational processing of polyubiquitin produced de novo in response to induction of the polyubiquitin genes seen under these conditions. Deubiquitinating enzymes thus appear involved in muscle wasting and implicate a widening web of regulation of genes in the ubiquitin system in this process.

Citing Articles

Deubiquitinases in muscle physiology and disorders.

Olie C, OBrien D, Jones H, Liang Z, Damianou A, Sur-Erdem I Biochem Soc Trans. 2024; 52(3):1085-1098.

PMID: 38716888 PMC: 11346448. DOI: 10.1042/BST20230562.


Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders.

Kitamura H Int J Mol Sci. 2023; 24(4).

PMID: 36834633 PMC: 9966627. DOI: 10.3390/ijms24043219.


Emerging Role of Ubiquitin-Specific Protease 19 in Oncogenesis and Cancer Development.

Rossi F, Rossi M Front Cell Dev Biol. 2022; 10:889166.

PMID: 35646888 PMC: 9133600. DOI: 10.3389/fcell.2022.889166.


USP19 promotes hypoxia-induced mitochondrial division via FUNDC1 at ER-mitochondria contact sites.

Chai P, Cheng Y, Hou C, Yin L, Zhang D, Hu Y J Cell Biol. 2021; 220(7).

PMID: 33978709 PMC: 8127008. DOI: 10.1083/jcb.202010006.


USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer.

Rossi F, Enrique Steinberg J, Calvo Roitberg E, Joshi M, Pandey A, Abba M Oncogenesis. 2021; 10(3):28.

PMID: 33714979 PMC: 7956144. DOI: 10.1038/s41389-021-00318-x.